Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

RATIO-CEFUROXIME DIN 02242656

Status: Cancelled Post Market
Holder: TEVA CANADA LIMITED
Molecule: CEFUROXIME (CEFUROXIME AXETIL)

Health Canada record

Active ingredient(s)CEFUROXIME (CEFUROXIME AXETIL) 250 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ01DC02 CEFUROXIME
Original market date30-Aug-2001
Current status date04-Sep-2019
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CEFUROXIME (CEFUROXIME AXETIL)

DINProductCompanyFormStrengthStatus
02244393APO-CEFUROXIMEAPOTEX INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGMarketed
02244394APO-CEFUROXIMEAPOTEX INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGMarketed
02344823AURO-CEFUROXIMEAURO PHARMA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGMarketed
02344831AURO-CEFUROXIMEAURO PHARMA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGMarketed
02212307CEFTINSANDOZ CANADA INCORPORATEDGranules For SuspensionCEFUROXIME (CEFUROXIME AXETIL) 125 MGMarketed
02547201JAMP CEFUROXIMEJAMP PHARMA CORPORATIONTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGMarketed
02547198JAMP CEFUROXIMEJAMP PHARMA CORPORATIONTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGMarketed
02212293CEFTIN - PWR 250MG/SACHETGLAXOSMITHKLINE INCPowderCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market
02212277CEFTIN - TAB 250MGGLAXOSMITHKLINE INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market
02212285CEFTIN - TAB 500MGGLAXOSMITHKLINE INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Post Market
02145286CEFTIN FOR ORAL SUSPENSION-PWS 250MG/PCKGLAXO CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market
01943049CEFTIN PWS 125MG/5MLGLAXO CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME AXETIL) 125 MGCancelled Post Market
00886890CEFTIN TAB 250MGGLAXO CANADA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market
00886904CEFTIN TAB 500MGGLAXO CANADA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Post Market
02230127NOVO-CEFUROXIMENOVOPHARM LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Pre Market
02230125NOVO-CEFUROXIMENOVOPHARM LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 125 MGCancelled Pre Market
02230126NOVO-CEFUROXIMENOVOPHARM LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Pre Market
02336456NU-CEFUROXIMENU-PHARM INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled (Unreturned Annual)
02336448NU-CEFUROXIMENU-PHARM INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled (Unreturned Annual)
02323125ORB-CEFUROXIMEORBUS PHARMA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled (Unreturned Annual)
02323117ORB-CEFUROXIMEORBUS PHARMA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled (Unreturned Annual)
02311453PRO-CEFUROXIME - 500PRO DOC LIMITEETabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Post Market
02242657RATIO-CEFUROXIMETEVA CANADA LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
181082016-05-13Supplement to a New Drug Submission (SNDS)PRODUCT MONOGRAPH UPDATE TO MATCH THE INNOVATOR'S PRODUCT MONOGRAPH
142302013-03-20New Drug Submission (NDS)Manufacturer name change
3462002-08-27New Drug Submission (NDS)MANUFACTURER AND PRODUCT NAME CHANGE
10402000-08-15New Drug Submission (NDS)
Request a quote for RATIO-CEFUROXIME

How to read a Canadian DIN record